Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phoebe Rich

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Cutis|May 1, 2007
Modern methods to treat superficial fungal diseaseJames Q Del Rosso, Zoe Diana Draelos, Joseph L Jorizzo, et al.
Journal of Drugs in Dermatology : JDD|July 26, 2013
Onchomycosis: an overviewBoni E Elewski, Phoebe Rich, Antonella Tosti, et al.
Skin Appendage Disorders|February 7, 2022
Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail SpecialistsShari R Lipner, Mahmoud Ghannoum, Molly A Hinshaw, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for OnychomycosisSteven R Feldman, Tracey C Vlahovic, Warren S Joseph, et al.
Cutis|November 15, 2017
Clinical trial designs for topical antifungal treatments of onychomycosis and implications on clinical practicePhoebe Rich, Tracey C Vlahovic, Warren S Joseph, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the USShari R Lipner, Warren S Joseph, Tracey C Vlahovic, et al.
The Journal of Dermatological Treatment|November 12, 2016
Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasisNeil J Korman, Howard Sofen, Scott Fretzin, et al.
The Journal of Dermatological Treatment|March 1, 2021
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasisKristian Reich, Curdin Conrad, Lars Erik Kristensen, et al.
The Journal of Rheumatology|January 12, 2007
The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritisSarah E Cassell, Jeffry D Bieber, Phoebe Rich, et al.
The Journal of Dermatological Treatment|October 2, 2023
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeksAlexander Egeberg, Lars Erik Kristensen, Luis Puig, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Cutis|May 1, 2007
Modern methods to treat superficial fungal diseaseJames Q Del Rosso, Zoe Diana Draelos, Joseph L Jorizzo, et al.
Journal of Drugs in Dermatology : JDD|July 26, 2013
Onchomycosis: an overviewBoni E Elewski, Phoebe Rich, Antonella Tosti, et al.
Skin Appendage Disorders|February 7, 2022
Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail SpecialistsShari R Lipner, Mahmoud Ghannoum, Molly A Hinshaw, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for OnychomycosisSteven R Feldman, Tracey C Vlahovic, Warren S Joseph, et al.
Cutis|November 15, 2017
Clinical trial designs for topical antifungal treatments of onychomycosis and implications on clinical practicePhoebe Rich, Tracey C Vlahovic, Warren S Joseph, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the USShari R Lipner, Warren S Joseph, Tracey C Vlahovic, et al.
The Journal of Dermatological Treatment|November 12, 2016
Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasisNeil J Korman, Howard Sofen, Scott Fretzin, et al.
The Journal of Dermatological Treatment|March 1, 2021
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasisKristian Reich, Curdin Conrad, Lars Erik Kristensen, et al.
The Journal of Rheumatology|January 12, 2007
The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritisSarah E Cassell, Jeffry D Bieber, Phoebe Rich, et al.
The Journal of Dermatological Treatment|October 2, 2023
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeksAlexander Egeberg, Lars Erik Kristensen, Luis Puig, et al.
Pageof 9